Attract talent




CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range ...


Add photos to showcase CureVac’s culture


Add CureVac’s values

Insider experiences

Share your experience of working at CureVac

Igor Splawski
Chief Scientific Officer
Mariola Fotin-Mleczek
Chief Technology Officer
Pierre Kemula
Chief Financial Officer
Antony Blanc
Chief Business Officer and Chief Commercial Officer
Vita Ulrike Gnad-Vogt
Chief Development Officer
Malte Greune
Chief Operating Officer
Vita Klaus Edvardsen
Chief Development Officer

Add your teams to show how people work together at CureVac

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.